Order Article Reprints

Hofer T, Rossi M, Carboni S, Di Berardino Besson W, von Laer D, Wollmann G, Derouazi M, Santiago-Raber M-L. Heterologous Prime-Boost Vaccination with a Peptide-Based Vaccine and Viral Vector Reshapes Dendritic Cell, CD4+ and CD8+ T Cell Phenotypes to Improve the Antitumor Therapeutic Effect. Cancers. 2021; 13(23):6107. https://doi.org/10.3390/cancers13236107

Hofer, Tamara, Matteo Rossi, Susanna Carboni, Wilma Di Berardino Besson, Dorothee von Laer, Guido Wollmann, Madiha Derouazi, and Marie-Laure Santiago-Raber. 2021. "Heterologous Prime-Boost Vaccination with a Peptide-Based Vaccine and Viral Vector Reshapes Dendritic Cell, CD4+ and CD8+ T Cell Phenotypes to Improve the Antitumor Therapeutic Effect" Cancers 13, no. 23: 6107. https://doi.org/10.3390/cancers13236107

Hofer, T., Rossi, M., Carboni, S., Di Berardino Besson, W., von Laer, D., Wollmann, G., Derouazi, M., & Santiago-Raber, M.-L. (2021). Heterologous Prime-Boost Vaccination with a Peptide-Based Vaccine and Viral Vector Reshapes Dendritic Cell, CD4+ and CD8+ T Cell Phenotypes to Improve the Antitumor Therapeutic Effect. Cancers, 13(23), 6107. https://doi.org/10.3390/cancers13236107